(Total Views: 405)
Posted On: 08/19/2020 12:02:34 PM
Post# of 154055
I don't disagree with your points.
And I'd add that with a molecule that has as much promise as leronlimab, where are the Baker Brothers, the Perceptives, and all of the other biotech-focused hedge funds that don't care if a company is listed on OTC?
I can wait for leronlimab to capture its first approval, as I am certain that the institutional flood gates will open ... not to mention BP having to face the reality that the horses have left the barn.
And I'd add that with a molecule that has as much promise as leronlimab, where are the Baker Brothers, the Perceptives, and all of the other biotech-focused hedge funds that don't care if a company is listed on OTC?
I can wait for leronlimab to capture its first approval, as I am certain that the institutional flood gates will open ... not to mention BP having to face the reality that the horses have left the barn.
(3)
(0)
